IP Library Granted Patent US 6,955,921
Granted Patent B2
US 6,955,921 · App. 10/287,239 · Granted Oct 18, 2005

Trypsin substrate and diagnostic device, and method of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,955,921
App. No.
10/287,239
Granted
Oct 18, 2005
Kind
B2
Abstract

A compound of the formula (I) wherein R 1 is a protecting group for Nα, R 2 is a protecting group for N G , and R 3 is aryl, and wherein the compound of formula (I) is a trypsin substrate such that trypsin cleaves the O—C single bond, which liberates R 3 —OH; a diagnostic device comprising same; a method for preparing the diagnostic device; and a method of using the diagnostic device to detect levels of urinary trypsin inhibitor in a biological sample; and a diagnostic kit for detecting levels of urinary trypsin inhibitor in a biological sample.

Claims (29)

1. A diagnostic device comprising:

a carrier matrix; and

a compound of the formula (I)

wherein R 1 is a protecting group for Nα;

R 2 is a protecting group for N G ; and

R 3 is aryl;

wherein the compound of formula (I) is a trypsin substrate such that trypsin cleaves the O—C single bond, which liberates R 3 —OH.

2. The diagnostic device of claim 1 wherein R 1 is selected from the group consisting of acyl, arene sulfonyl, and carbamoyl derivatives.

3. The diagnostic device of claim 1 wherein R 1 is selected from the group consisting of t-butyloxycarbonyl and derivatives, benzyloxycarbonyl and derivatives, benzoyl and derivatives, and benzene sulfonyl and derivatives.

4. The diagnostic device of claim 1 wherein R 2 is selected from the group consisting of nitro, arene sulfonyl, carbamoyl, and acyl.

5. The diagnostic device of claim 1 wherein R 2 is selected from the group consisting of nitro, benzene sulfonyl and derivatives, tosyl, carbobenzyloxy and derivatives, and benzoyl and derivatives.

6. The diagnostic device of claim 1 wherein R 3 comprises a heterocyclic aromatic moiety.

7. The diagnostic device of claim 6 wherein R 3 is a fused ring system.

8. The diagnostic device of claim 1 wherein R 3 is carbocyclic.

9. The diagnostic device of claim 8 wherein R 3 is 1-naphthol and derivatives thereof.

10. The diagnostic device of claim 1 wherein R 3 is selected from the group consisting of phenylpyrrole and derivatives thereof, coumarin and derivatives thereof, phenylthiophene and derivatives thereof, indole and derivatives thereof, and 2-phenyl-5H-thiazol and derivatives thereof.

11. The diagnostic device of claim 1 wherein the carrier matrix is filter paper.

12. The diagnostic device of claim 1 wherein the carrier matrix contains a diazonium salt.

13. The diagnostic device of claim 12 wherein R 3 —OH reacts with a diazonium salt to form a visible color.

14. The diagnostic device of claim 12 wherein the diazonium salt has the structure:

R 4 —N 2 + An −

wherein R 4 is aryl; and

wherein An − is an anion.

15. The diagnostic device of claim 14 wherein R 4 is morpholinobenzene and derivatives thereof.

16. The diagnostic device of claim 12 wherein the diazonium salt is a zwitter ion having the structure

wherein D − is an anion;

wherein G is independently H, C 1-6 alkyl, or in which the two G moieties together form a fused ring system; and

wherein B is H or OH.

17. The diagnostic device of claim 1 wherein R 3 —OH is optically distinct from the compound of formula (I).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2010
From: BAYER CORPORATION
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 024140/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2003
From: COREY, PAUL F.; FELMAN, STEVEN W.; REHM, GARY E.; PUGIA, MICHAEL J.
To: BAYER CORPORATION
Reel/Frame 013673/0612 →